Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen
- PMID: 164507
Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen
Abstract
Soluble antigen (SA) preparations were obtained from cell cultures infected with either the Davis or AD169 strains of cytomegalovirus (CMV). Fractionation of SA preparations through Sephadex G-200 resulted in a molecular weight value ranging from 67,000 to 85,000. Rate-zonal centrifugation produced an approximate value of 5.5S for the CMV antigenic material. Antisera to SA prepared from either AD169- or Davis-infected cells lacked neutralizing activity but produced specific fluorescence confined to CMV intranuclear inclusion material when used in the indirect fluorescent antibody test (IFA). The specific fluorescing inclusion reaction was seen when either AD169 or Davis antisera were used with cells infected with the Davis, AD169, Kerr, or C-87 strains of CMV. Fluorescence was not observed in cells infected with a strain of Herpes simplex type 1, varicella-zoster virus, an EBV transformed lymphocyte line, the Cx-90-3B human CMV transformed hamster embryo cell line or CMV-infected cell cultures treated with cytosine arabinoside (Ara-C) and showing only antigens expressed in the absence of viral DNA synthesis. Antisera prepared to SA preparations obtained from CMV-infected cells apparently react with specific CMV antigens that are dependent on viral DNA synthesis and are common to several strains.
Similar articles
-
Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.Infect Immun. 1976 Nov;14(5):1184-90. doi: 10.1128/iai.14.5.1184-1190.1976. Infect Immun. 1976. PMID: 185151 Free PMC article.
-
Cytomegalovirus antigenic heterogeneity can cause false-negative results in indirect hemagglutination and complement fixation antibody assays.J Clin Microbiol. 1985 Nov;22(5):768-71. doi: 10.1128/jcm.22.5.768-771.1985. J Clin Microbiol. 1985. PMID: 2997271 Free PMC article.
-
Production of polyclonal antisera against cytomegalovirus and varicella-zoster virus by use of affinity-purified viral antigens.APMIS. 1989 Mar;97(3):267-73. doi: 10.1111/j.1699-0463.1989.tb00787.x. APMIS. 1989. PMID: 2540778
-
Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus.Proc Natl Acad Sci U S A. 1984 Feb;81(3):876-80. doi: 10.1073/pnas.81.3.876. Proc Natl Acad Sci U S A. 1984. PMID: 6199788 Free PMC article.
-
Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests.J Immunol. 1974 Feb;112(2):528-32. J Immunol. 1974. PMID: 4360544 No abstract available.
Cited by
-
Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.Infect Immun. 1976 Nov;14(5):1184-90. doi: 10.1128/iai.14.5.1184-1190.1976. Infect Immun. 1976. PMID: 185151 Free PMC article.
-
Blastogenic response of human lymphocytes to human cytomegalovirus.Clin Exp Immunol. 1977 Oct;30(1):44-9. Clin Exp Immunol. 1977. PMID: 203423 Free PMC article.
-
Confirmation of human cytomegalovirus by reverse passive hemagglutination with monoclonal antibodies reactive to the major glycosylated peptide (GP-66).J Clin Microbiol. 1986 Sep;24(3):474-7. doi: 10.1128/jcm.24.3.474-477.1986. J Clin Microbiol. 1986. PMID: 2428828 Free PMC article.
-
Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus.Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):504-11. doi: 10.1007/BF02113428. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7588823
-
Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.Infect Immun. 1982 Jun;36(3):933-42. doi: 10.1128/iai.36.3.933-942.1982. Infect Immun. 1982. PMID: 6284646 Free PMC article.